Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
Alunno A, Carubbi F, Tan AL, Sen P, Cavagna L, Joshi M, Day J, Saha S, Gutiérrez CET, Caballero-Uribe CV, Distler O, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Alunno A, et al. Rheumatol Int. 2024 Sep;44(9):1725-1731. doi: 10.1007/s00296-024-05654-w. Epub 2024 Jul 13. Rheumatol Int. 2024. PMID: 39003346 Free PMC article.
Reduced Health-Related Quality of Life in Patients With Systemic Sclerosis: A Cross-Sectional Analysis of PROMIS Global Health Data From the International COVAD-2 e-Survey.
Yomono K, Li Y, Maroufy V, Ravichandran N, Yoshida A, Jagtap K, Velikova T, Sen P, Cavagna L, Agarwal V, Knitza J, Makol A, Dey D, Gutiérrez CET, Chatterjee T, Patel A, Gupta L, Agarwal V, Kuwana M; COVAD study group. Yomono K, et al. Int J Rheum Dis. 2025 Feb;28(2):e70101. doi: 10.1111/1756-185X.70101. Int J Rheum Dis. 2025. PMID: 39895251 No abstract available.
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study.
Shaharir SS, Nawi AM, Mariamutu TN, Kamaruzaman L, Said MSM, Rajalingham S, Parodis I, Sarkar M, Shinjo SK, Kadam E, Ziade N, Tan CL, Gullemin F, Caballero-Uribe CV, Tan AL, Andreoli L, Parihar J, Yaadav P, Saha S; COVAD Study Group; Gupta L, Agarwal V. Shaharir SS, et al. Int J Rheum Dis. 2025 Jan;28(1):e70043. doi: 10.1111/1756-185X.70043. Int J Rheum Dis. 2025. PMID: 39791506